Case studies where remaining host cell-derived proteins, etc. in biopharmaceuticals became problems in terms of their immunogenicity, adjuvant activity and safety [Part 1]

NIIMI SHINGO

Art

J-GLOBAL ID：202002234764317322 Reference number：20A0889176

Case studies where remaining host cell-derived proteins, etc. in biopharmaceuticals became problems in terms of their immunogenicity, adjuvant activity and safety [Part 1]

バイオ医薬品に残存する宿主細胞由来タンパク質などが免疫原性,アジュバント活性および安全性の観点から臨床試験において問題となったケーススタディその1

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=20A0889176&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0889176&from=J-GLOBAL&jstjournalNo=X0346A") }}

Author (1)：
Material：
Volume： 36 Issue： 5 Page： 843-850 Publication year： Apr. 01, 2020
JST Material Number： X0346A ISSN： 0910-4739 Document type： Article
Article type：解説 Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0889176&from=J-GLOBAL&jstjournalNo=X0346A") }}

Physicochemical pharmacy in general

, , , , , , , , , ,

Return to Previous Page